Emulsifier-Modulated Microstructure of Soy Protein-Arabinoxylan Oleogels Improves Astaxanthin Bioaccessibility and In Vivo Antioxidant Activity.

Xiaolong Shen, Wenhao Hu, Wenrong Meng, Tiancheng Sheng, Xiuhong Zhao, Jiaxin Li, Qingyu Yang, Longkun Wu

Abstract read

In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Structural Engineering of Edible Oleogels: From Molecular Assembly to Functional Food Applications.Gels (Basel, Switzerland) · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaolong ShenSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Wenhao HuSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Wenrong MengSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Tiancheng ShengSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Xiuhong ZhaoSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Jiaxin LiSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Qingyu YangSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Longkun WuSchool of Food Science and Technology, Shenyang Normal University, Shenyang 110031, China.

Funding

2025 Liaoning Provincial Natural Science Foundation General Program 2025-MS-2752025 Liaoning Provincial Science and Technology Commissioner Program Na

6 · The paper itself

Abstract

Astaxanthin (AST), despite its high bioactivity, exhibits poor stability and low bioavailability due to its strong lipophilicity and inherent degradation susceptibility. To overcome such a challenge, we developed a food-grade oleogel delivery system using a soy protein-arabinoxylan (SA) glycosylated complex modulated by different concentrations (0.5-3%) of sucrose ester (SE) or soy lecithin. We show that the emulsifier concentration has a non-linear effect on the oleogel microstructure: an optimal level of 1% had a significant impact on the interfacial compactness and network density, giving rise to improved thermal stability, rheological strength and AST encapsulation efficiency (81.27%). During in vitro digestion, the SA matrix in combination with emulsifiers allowed gastric protection and intestinal-targeted release of AST with a bioaccessibility of up to 88.84% (SAO-SE-AST). This controlled release profile directly translated into enhanced in vivo antioxidant efficacy in wild-type Bristol N2

Indexed as

arabinoxylanastaxanthinemulsifieroleogelsoy protein

Identifiers

PMID42073202

DOI10.3390/foods15081315

PMCPMC13114323

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.